Coastwise Capital Group, LLC Amgen Inc Transaction History

Coastwise Capital Group, LLC

$121 Million
Q3 2024

A detailed history of Coastwise Capital Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Coastwise Capital Group, LLC holds 2,247 shares of AMGN stock, worth $661,808. This represents 0.6% of its overall portfolio holdings.

Number of Shares

2,247

Previous 2,142 4.9%

Holding current value

$661,808

Previous $669,000 8.22%

% of portfolio

0.6%

Previous 0.65%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $32,484 - $35,424	105 Added 4.9%	2,247 $724,000
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $52,812 - $64,181	-201 Reduced 8.58%	2,142 $669,000
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $106,472 - $128,525	-396 Reduced 14.46%	2,343 $666,000
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $8,693 - $9,807	-34 Reduced 1.23%	2,739 $788,000
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $223,023 - $276,889	1,020 Added 58.19%	2,773 $745,000
Q2 2023 Aug 10, 2023	BUY	$214.27 - $253.37 $21,855 - $25,843	102 Added 6.18%	1,753 $389,000
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $68,640 - $83,660	304 Added 22.57%	1,651 $399,000
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $43,973 - $55,873	192 Added 16.62%	1,347 $353,000
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $21,323 - $24,049	-95 Reduced 7.6%	1,155 $260,000
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $67,598 - $75,224	-293 Reduced 18.99%	1,250 $304,000
Q1 2022 Aug 15, 2022	BUY	$219.27 - $242.57 $338,333 - $374,285	1,543 New	1,543 $373,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastwise Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coastwise Capital Group, LLC with notifications on news.

Account

Coastwise Capital Group, LLC Amgen Inc Transaction History